1. Home
  2. CUZ vs ARQT Comparison

CUZ vs ARQT Comparison

Compare CUZ & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cousins Properties Incorporated

CUZ

Cousins Properties Incorporated

HOLD

Current Price

$23.02

Market Cap

3.9B

Sector

Real Estate

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$24.10

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUZ
ARQT
Founded
1958
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.3B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CUZ
ARQT
Price
$23.02
$24.10
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$28.33
$34.00
AVG Volume (30 Days)
1.8M
1.1M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
5.59%
N/A
EPS Growth
N/A
88.79
EPS
0.24
N/A
Revenue
$993,816,000.00
$376,072,000.00
Revenue This Year
$5.31
$34.46
Revenue Next Year
$4.14
$29.77
P/E Ratio
$95.42
N/A
Revenue Growth
16.00
91.34
52 Week Low
$21.03
$12.42
52 Week High
$30.80
$31.77

Technical Indicators

Market Signals
Indicator
CUZ
ARQT
Relative Strength Index (RSI) 52.28 52.30
Support Level $21.11 $22.56
Resistance Level $23.37 $25.03
Average True Range (ATR) 0.68 0.91
MACD 0.15 0.32
Stochastic Oscillator 82.06 76.21

Price Performance

Historical Comparison
CUZ
ARQT

About CUZ Cousins Properties Incorporated

Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: